HLA-C and neoplasm: Comprising antibody-derived variable regions, CAR-T cells are capable of skipping major histocompatibility complex (MHC) expression and presentation by tumor cells or professional antigen presenting cells (APC) and directly recognize extracellular domains and proteins on, for example, tumor cells (tumor antigens).